Charles Schwab
MBOT icon

Charles Schwab’s Microbot Medical MBOT Stock Holding History

Charles Schwab’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.5K Hold
50,000
– – ﹤0.01% 3409
2026
Q1 		$121K Buy
+50,000
New +$112K ﹤0.01% 3360

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Charles Schwab's MBOT Position: Q2 2026 in Review

Charles Schwab held its Microbot Medical (MBOT) position steady in Q2 2026 at 50,000 shares worth $97.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Charles Schwab first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $121K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Charles Schwab held 50,000 shares of Microbot Medical worth $97.5K as of Q2 2026.
  • Charles Schwab left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3409 holding.
  • Charles Schwab first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • Charles Schwab's Microbot Medical position peaked at $121K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.